BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28369)

  • 1. Low molecular weight C1q-precipitins in hypocomplementemic vasculitis-urticaria syndrome: partial purification and characterization as immunoglobulin.
    Marder RJ; Burch FX; Schmid FR; Zeiss CR; Gewurz H
    J Immunol; 1978 Aug; 121(2):613-8. PubMed ID: 28369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
    Wisnieski JJ; Jones SM
    J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
    Wisnieski JJ; Naff GB
    Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of C1q found in a patient with hypocomplementemic vasculitis-urticaria syndrome.
    Sasaki T; Yonemasu K; Matsumoto M; Nagaki K
    Microbiol Immunol; 1989; 33(5):413-22. PubMed ID: 2502705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypocomplementemic urticarial vasculitis syndrome].
    Sessler R; Hasche G; Olbricht CJ
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):1003-6. PubMed ID: 11004912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1q deficiency associated with urticarial-like lesions and cutaneous vasculitis.
    Marder RJ; Rent R; Choi EY; Gewurz H
    Am J Med; 1976 Oct; 61(4):560-5. PubMed ID: 973650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLq precipitin in the sera of patients with allergic vasculitis (Gougerot-Ruiter Syndrome).
    Asghar SS; Cormane RH; Faber WR
    J Invest Dermatol; 1975 Feb; 64(2):113-8. PubMed ID: 1168226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ecchymotic angioedema revealing childhood systemic lupus erythematosus with anti-C1q antibodies].
    Frot AS; Barbarot S; Poignant S; Guyot C; Stalder JF
    Ann Dermatol Venereol; 2008; 135(8-9):584-6. PubMed ID: 18789294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular disease in two patients with urticaria-cutaneous vasculitis and hypocomplementemia.
    Schultz DR; Perez GO; Volanakis JE; Pardo V; Moss SH
    Am J Kidney Dis; 1981 Nov; 1(3):157-65. PubMed ID: 7332008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypocomplementemic urticarial vasculitis with glomerulopathy and renal venulitis].
    Meyrier A; Français P; Lesavre P; Mougenot B; Ronco P; Jeanmougin M; Français C
    Nephrologie; 1984; 5(1):1-7. PubMed ID: 6728099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases.
    Wisnieski JJ; Jones SM
    J Rheumatol; 1992 Jun; 19(6):884-8. PubMed ID: 1404125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.
    Kauffmann RH; Herrmann WA; Meijer CJ; Daha MR; Vanes LA
    Clin Exp Immunol; 1980 Sep; 41(3):459-70. PubMed ID: 7438561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in cutaneous vasculitis. Detection with C1q and monoclonal rheumatoid factor.
    Mackel SE; Tappeiner G; Brumfield H; Jordan RE
    J Clin Invest; 1979 Dec; 64(6):1652-60. PubMed ID: 500831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight C1q in systemic lupus erythematosus.
    Hoekzema R; Hannema AJ; Swaak TJ; Paardekooper J; Hack CE
    J Immunol; 1985 Jul; 135(1):265-71. PubMed ID: 3923103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and partial characterization of a C1q inhibitor from the membranes of human peripheral blood lymphocytes.
    Ghebrehiwet B; Hamburger M
    J Immunol; 1982 Jul; 129(1):157-62. PubMed ID: 6979565
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and partial characterization of human platelet C1q binding sites.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1988 Nov; 141(10):3505-11. PubMed ID: 3183380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.